Abstract
AS THE COST OF genomic sequencing plunges, dozens of companies are popping up on the Internet, hoping to cash in on the increasing demand for personal genetic information. For a few hundred dollars, consumers can spit into a collection device and send their saliva sample to obtain a personalized genetic profile that will tell them about their ancestry, their risk of developing particular diseases, and various traits like their food preferences or athletic ability. But an increasing number of people are raising concerns about these direct-to-consumer (DTC) genetic tests and are calling for more government oversight. They question the technical performance of the tests, their clinical utility, and the likelihood that they will make a difference in an individual’s health. Some also worry about privacy and who should have access to a person’s genetic information. At a two-day workshop earlier this month, sponsored jointly by the National Academy of Sciences and the Institute of Medicine, ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
